Muammar Kabir

Muammar Kabir

Auto-generated profile, based on publicly available information

Muammar Kabir

Cancer Digital Intelligence, University Health Network, Toronto, Canada

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Sleep Medicine
Verified
Journal Article
Closed access
SSShumit Saha
Shumit Saha
MKMuammar Kabir
Muammar Kabir
NGNasim Montazeri Ghahjaverestan
Nasim Montazeri Ghahjaverestan
MHMaziar Hafezi
Maziar Hafezi
BGBojan Gavrilovic
Bojan Gavrilovic
AYAzadeh Yadollahi
Azadeh Yadollahi

1 January 2018 in Journal of Electrocardiology
Verified
Journal Article
Closed access
EPErick A. Perez-Alday
Erick A. Perez-Alday
JTJason A. Thomas
Jason A. Thomas
MKMuammar Kabir
Muammar Kabir
GSGolriz Sedaghat
Golriz Sedaghat
NRNichole Rogovoy
Nichole Rogovoy
LTLarisa G. Tereshchenko
Larisa G. Tereshchenko

1 November 2018 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
JTJason A. Thomas
Jason A. Thomas
EPErick Andres Perez-Alday
Erick Andres Perez-Alday
CHChristopher Hamilton
Christopher Hamilton
MKMuammar M. Kabir
Muammar M. Kabir
EPEugene A. Park
Eugene A. Park
LTLarisa G. Tereshchenko
Larisa G. Tereshchenko

1 September 2025 in JCO Clinical Cancer Informatics
Verified
Journal Article
Open access
BYBaijiang Yuan
Baijiang Yuan
MKMuammar Kabir
Muammar Kabir
JHJiang Chen He
Jiang Chen He
YLYuchen Li
Yuchen Li
BGBenjamin Grant
Benjamin Grant
RGRobert C. Grant
Robert C. Grant
PURPOSE: Cancer and its treatment cause symptoms. In this study, we aimed to develop machine learning (ML) systems that predict future symptom deterioration among people receiving treatment for cancer and then validate the systems in a simulated deployment across an entire health care system. METHODS: We trained and tested ML systems that predict a deterioration in nine patient-reported symptoms within 30 days after treatments for aerodigestive cancers, using internal electronic health record (EHR) data at Princess Margaret Cancer Centre (3,229 patients; 20,267 treatments). The primary performance metric was the area under the receiver operating characteristic curve (AUROC). The best-performing systems in the held-out internal test set were then externally validated across 82 cancer centers in Ontario (12,079 patients; 77,003 treatments) by adapting techniques from meta-analysis. RESULTS: The best ML systems predicted symptom deterioration with AUROCs ranging from 0.66 (95% CI, 0.63 to 0.69) for dyspnea to 0.73 (95% CI, 0.71 to 0.75) for drowsiness in the internal test cohort. Treatments flagged as high-risk were significantly associated with future symptom deterioration (odds ratios [ORs], 2.53-6.56; all P < .001) and emergency department visits for dyspnea (OR, 1.85; P = .008), depression (OR, 1.84; P = .04), and anxiety (OR, 2.66; P < .001). In the external validation cohort, the AUROCs for different symptoms meta-analyzed across centers ranged from 0.67 (95% CI, 0.66 to 0.68) to 0.73 (95% CI, 0.72 to 0.74). Performance across centers displayed significant heterogeneity for six of nine symptoms (I 2 , 46.4%-66.9%; P = .004 for dyspnea, P < .001 for the rest). CONCLUSION: ML can predict future symptoms among people with cancer from routine EHR data, which could guide personalized interventions. Heterogeneous performance across centers must be considered when systems are deployed across a health care system.

1 October 2024 in Nature and Science of Sleep
Verified
Journal Article
Open access
PDF file
MKMuammar M Kabir
Muammar M Kabir
AAAtousa Assadi
Atousa Assadi
SSShumit Saha
Shumit Saha
BGBojan Gavrilovic
Bojan Gavrilovic
KZKaiyin Zhu
Kaiyin Zhu
AYAzadeh Yadollahi
Azadeh Yadollahi
Purpose: Cardiovascular disorders are the leading cause of mortality worldwide with obstructive sleep apnea (OSA) as the independent risk factor. Heart sounds are strong modalities to obtain clinically relevant information regarding the functioning of the heart valves and blood flow. The objective of this study was to use a small wearable device to record and investigate the changes in heart sounds during respiratory events (reduction and cessation of breathings) and their association with oxyhemoglobin desaturation (hypoxemia). Patients and Methods: Sleep assessment and tracheal respiratory and heart sounds were recorded simultaneously from 58 individuals who were suspected of having OSA. Sleep assessment was performed using in-laboratory polysomnography. Tracheal respiratory and heart sounds were recorded over the suprasternal notch using a small device with embedded microphone and accelerometer called the Patch. Heart sounds were extracted from bandpass filtered tracheal sounds using smoothed Hilbert envelope on decomposed signal. For each individual, data from 20 obstructive events during Non-Rapid Eye Movement stage-2 of sleep were randomly selected for analysis. Results: A significant increase in heart sounds’ intensities from before to after the termination of respiratory events was observed. Also, there was a significant positive correlation between the magnitude of hypoxemia and the increase in heart sounds’ intensities (r> 0.82, p< 0.001). In addition, the changes in heart sounds were significantly correlated with heart rate and blood pressure. Conclusion: Our results indicate that heart sound analysis can be used as an alternative modality for assessing the cardiovascular burden of sleep apnea, which may indicate the risk of cardiovascular disorders.

1 November 2016 in Journal of Electrocardiology
Verified
Journal Article
Closed access
GSGolriz Sedaghat
Golriz Sedaghat
EGElyar Ghafoori
Elyar Ghafoori
JWJonathan W. Waks
Jonathan W. Waks
MKMuammar M. Kabir
Muammar M. Kabir
ASAlexei Shvilkin
Alexei Shvilkin
LTLarisa G. Tereshchenko
Larisa G. Tereshchenko